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Abstract
Current evidence regarding potentially different host response
mechanisms in sepsis according to the type of initiating infection is
sporadic. It is possible that alterations in cell populations, variations
in effector molecules, and the degree of apoptosis differ between
sepsis caused by ventilator-associated pneumonia (VAP) and non-
VAP sepsis. VAP is one of the most common infections and
leading causes of sepsis in the intensive care unit, and mortality
remains high. A better understanding of the unique pathophysio-
logic features of VAP is needed in order to develop interventions
that target those specific pathways.
Ventilator-associated pneumonia (VAP) develops commonly
in mechanically ventilated patients and is a major cause of
morbidity and mortality in the intensive care unit. In a study
published in this issue of Critical Care, Pelekanou and
colleagues [1] investigated the differences in innate and
adaptive immune responses in 36 septic patients with VAP
and 32 patients with sepsis due to other infections, like
pyelonephritis, bacteremia, intra-abdominal infection, and
community- and hospital-acquired pneumonia. There was
evidence of a more pronounced immunoparalysis in patients
with VAP than in those with other bacterial infections. This
was supported by the decreased number of CD3+/CD4+
cells, the increase in monocyte apoptosis, and the lower
release of pro-inflammatory cytokines, namely tumor necrosis
factor-alpha and interleukin-6, from monocytes after stimula-
tion with lipopolysaccharide (LPS) in the group of patients
with VAP.
It is known that anergic monocytes from patients with septic
shock showed increased susceptibility to apoptosis when
compared with monocytes from normal hosts [2]. Patients
with VAP are more compromised due to various factors like
critical illness, malnutrition, invasive interventions, and the
loss of anatomic defense mechanisms, some of which may
contribute to monocyte unresponsiveness or lymphocyte
depletion. The authors report that endotracheal intubation in
septic patients without VAP was not independently associa-
ted with similar numeric and functional alterations in lympho-
cytes and monocytes. Nevertheless, the study might have
been underpowered to detect such differences.
Additionally, one important finding of the study [1] was the
observation that septic patients with VAP whose monocytes
failed to adequately respond to monocyte stimulation had
decreased survival rates when compared with those with an
increased cytokine release from monocytes. A similar trend
was observed in non-VAP-related sepsis, but it was not
statistically significant. Previously published work from this
group had demonstrated that early monocyte apoptosis was
linked to survival advantage in patients with sepsis due to
VAP [3]. What remain to be determined are whether a
separate mechanism associated with monocyte anergy and
enhanced apoptosis exists in VAP-related sepsis and how is
it related to mortality.
One concept that may be useful in trying to answer this
question is the development of endotoxin tolerance. Mono-
cytes exposed to low doses of LPS exhibit a decreased
responsiveness to subsequent stimulation by endotoxin [4].
Endotoxin tolerance has been considered a paradigm of
immunoparalysis [5], which is present not only in sepsis but
also in systemic inflammatory response syndrome and other
diseases like cystic fibrosis and acute coronary syndrome
[6,7]. Endotoxin tolerance could support the theory of VAP
pathogenesis that is embraced by the authors. Gradual
exposure of the host to increasing bacterial inocula
originating from aspiration of oropharyngeal flora [8] may
contribute to a state of immunoparalysis through the
mechanism of endotoxin tolerance. However, the clinical
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implications of endotoxin tolerance continue to be elusive [4].
Although endotoxin tolerance has been implicated in
increased susceptibility to secondary infections, a number of
studies in experimental models of sepsis have exhibited a
protective role of endotoxin tolerance [9-11].
Using a model similar to that of endotoxin tolerance [12], the
authors attempted to mimic VAP pathogenesis by using
augmenting concentrations of Gram-negative bacteria to
sequentially stimulate ex vivo peripheral blood mononuclear
cells (PBMCs) isolated from healthy volunteers and assessed
their apoptosis parameters [1]. An increase in CD14 mono-
cyte apoptosis was observed when compared with non-
stimulated PBMCs and PBMCs that had only a unique
bacterial challenge with the highest concentration of bacterial
inoculum used.
Moreover, a question raised by the results is whether lympho-
cyte depletion, monocyte apoptosis, and monocyte anergy in
VAP are immunoparalysis markers that could be used as
prognostic factors or are underlying dysregulations that
contribute to the pathogenesis of VAP. Although patients in
the two groups did not differ significantly in terms of age,
disease severity, underlying conditions, diabetes mellitus,
corticosteroid use, the presence of other recent infections, or
additional factors that may affect the immune response to
sepsis, the duration of critical illness prior to enrollment was
not reported. It would be reasonable to expect a more fre-
quent occurrence of longer hospitalization, surgery, trauma,
neurosurgical conditions, or other critical illness prior to the
development of septic shock in the group of patients with
VAP. Thus, it is hard to know whether any of the above-men-
tioned factors independently contributed to the observed
monocyte unresponsiveness, monocyte apoptosis, and CD3/
CD4 cell decrease in this group, and more work is needed
before those changes are attributed solely to VAP.
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